Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 5;128(11):2085–2097. doi: 10.1002/cncr.34180

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Subgroup analysis of overall survival is illustrated in intent‐to‐treat patients. Note that hazard ratios (HRs) were not computed for subset categories that included <21 patients per treatment group. CI indicates confidence interval; IMDC, International Metastatic Renal Cell Carcinoma Database Consortium; mOS, median overall survival; N Europe, northern Europe; NE, not estimable; NIVO+IPI, nivolumab plus ipilimumab; PD‐L1, programmed death ligand 1; SUN, sunitinib; W Europe, western Europe.